Highmount Capital’s Allergan Inc AGN Stock Holding History

Highmount Capital’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,030	Closed	-$252K	–	149
2014 Q1	$252K	Hold	2,030	–	–	0.06%	133
2013 Q4	$225K	Buy	+2,030	New	+$194K	0.05%	134

Other funds holding AGN

PSCM

Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Highmount Capital's AGN Position: Q2 2014 in Review

Highmount Capital sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 2,030 shares — an estimated $252K sold.

Highmount Capital first reported a position in AGN in Q4 2013 and held it in 2 quarters. The position peaked at $252K in Q1 2014. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

Highmount Capital reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
Highmount Capital sold 2,030 Allergan Inc shares in Q2 2014, an estimated $252K.
Highmount Capital first reported a position in Allergan Inc in Q4 2013 and held it in 2 quarters.
Highmount Capital's Allergan Inc position peaked at $252K in Q1 2014.
770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Highmount Capital's 13F filing for Q2 2014, filed 12 Aug 2014.